UW-Madison researchers have been working with eGenesis, one of two companies that supplied gene-edited pig organs for four transplants on the East Coast in critically ill patients who died within a few months. The companies are seeking federal approval to start larger clinical trials, and UW could be a site.
Office of Strategic Communication